Home > Qtrly Results > GLAND PHARMA

GLAND PHARMA
Quarterly Results Analysis [Sep2024]

GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Quarterly Results

Consolidated Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
UnAudited
Jun2023
UnAudited
Mar2023
Audited
Dec2022
UnAudited
Revenues ₹1,406 Cr ₹1,402 Cr ₹1,537 Cr ₹1,545 Cr ₹1,373 Cr ₹1,209 Cr ₹785 Cr ₹938 Cr
Expenses ₹1,109 Cr ₹1,137 Cr ₹1,179 Cr ₹1,189 Cr ₹1,049 Cr ₹915 Cr ₹617 Cr ₹649 Cr
Operating Income ₹297 Cr ₹264 Cr ₹359 Cr ₹356 Cr ₹324 Cr ₹294 Cr ₹168 Cr ₹290 Cr
Other Income ₹60 Cr ₹51 Cr ₹42 Cr ₹37 Cr ₹53 Cr ₹38 Cr ₹39 Cr ₹62 Cr
Interest ₹6 Cr ₹6 Cr ₹10 Cr ₹5 Cr ₹6 Cr ₹5 Cr ₹2 Cr ₹3 Cr
Depreciation ₹94 Cr ₹92 Cr ₹93 Cr ₹105 Cr ₹81 Cr ₹65 Cr ₹38 Cr ₹38 Cr
Profit Before Tax ₹257 Cr ₹218 Cr ₹298 Cr ₹283 Cr ₹290 Cr ₹261 Cr ₹111 Cr ₹311 Cr
Profit After Tax ₹164 Cr ₹144 Cr ₹192 Cr ₹192 Cr ₹194 Cr ₹194 Cr ₹79 Cr ₹232 Cr
EPS ₹9.93 ₹8.73 ₹11.68 ₹11.65 ₹11.78 ₹11.79 ₹4.78 ₹14.08
Industry Peers & Returns1W1M1Y
GLAND PHARMA 0.9% 0.2% -2.5%
SUN PHARMACEUTICAL INDUSTRIES 1% 0.7% 47.3%
CIPLA 0.3% -1.8% 19.6%
DR REDDYS LABORATORIES 6% 11.8% 20.3%
ZYDUS LIFESCIENCES -1.5% -0.1% 47%
DIVIS LABORATORIES -1.1% -5.8% 61.7%
MANKIND PHARMA 3.7% 11.4% 59.4%
TORRENT PHARMACEUTICALS 0.6% 4.1% 59.5%
LUPIN 3.3% 2.9% 75.9%

GLAND PHARMA Quarterly Revenues

Revenues
Q-o-Q

0.29 %

Y-o-Y

2.36 %

Quarters Revenues % Change
Sep2024 ₹1,406 Cr
0.29
Jun2024 ₹1,402 Cr
-8.83
Mar2024 ₹1,537 Cr
-0.50
Dec2023 ₹1,545 Cr
12.50
Sep2023 ₹1,373 Cr
13.63
Jun2023 ₹1,209 Cr
53.97
Mar2023 ₹785 Cr
-16.34
Dec2022 ₹938 Cr -

GLAND PHARMA Quarterly Operating Profit

Operating Profit
Q-o-Q

12.35 %

Y-o-Y

-8.34 %

Quarters Operating Profit % Change
Sep2024 ₹297 Cr
12.35
Jun2024 ₹264 Cr
-26.28
Mar2024 ₹359 Cr
0.63
Dec2023 ₹356 Cr
9.97
Sep2023 ₹324 Cr
10.25
Jun2023 ₹294 Cr
74.54
Mar2023 ₹168 Cr
-41.84
Dec2022 ₹290 Cr -
Operating Margins
Q-o-Q

12.04 %

Y-o-Y

-10.47 %

Quarters Operating Margin% % Change
Sep2024 21.13%
12.04
Jun2024 18.86%
-19.16
Mar2024 23.33%
1.17
Dec2023 23.06%
-2.29
Sep2023 23.6%
-2.96
Jun2023 24.32%
13.38
Mar2023 21.45%
-30.49
Dec2022 30.86% -

GLAND PHARMA Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

13.75 %

Y-o-Y

-15.74 %

Quarters Profit After Tax % Change
Sep2024 ₹164 Cr
13.75
Jun2024 ₹144 Cr
-25.29
Mar2024 ₹192 Cr
0.29
Dec2023 ₹192 Cr
-1.15
Sep2023 ₹194 Cr
-0.01
Jun2023 ₹194 Cr
146.69
Mar2023 ₹79 Cr
-66.08
Dec2022 ₹232 Cr -
PAT Margins
Q-o-Q

13.35 %

Y-o-Y

-17.69 %

Quarters PAT Margin(%) % Change
Sep2024 11.63 %
13.35
Jun2024 10.26 %
-18.05
Mar2024 12.52 %
0.81
Dec2023 12.42 %
-12.10
Sep2023 14.13 %
-12.02
Jun2023 16.06 %
60.28
Mar2023 10.02 %
-59.47
Dec2022 24.72 % -

GLAND PHARMA Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

13.75 %

Y-o-Y

-15.70 %

Quarters EPS % Change
Sep2024 ₹9.93
13.75
Jun2024 ₹8.73
-25.26
Mar2024 ₹11.68
0.26
Dec2023 ₹11.65
-1.10
Sep2023 ₹11.78
-0.08
Jun2023 ₹11.79
146.65
Mar2023 ₹4.78
-66.05
Dec2022 ₹14.08 -

You may also like the below Video Courses